Efficacy and safety of procalcitonin guidance in reducing the duration of antibiotic treatment in critically ill patients: a randomised, controlled, open-label trial
Tóm tắt
Từ khóa
Tài liệu tham khảo
Van Boeckel, 2014, Global antibiotic consumption 2000 to 2010: an analysis of national pharmaceutical sales data, Lancet Infect Dis, 14, 742, 10.1016/S1473-3099(14)70780-7
Rice, 2008, The Maxwell Finland lecture: for the duration-rational antibiotic administration in an era of anti-microbial resistance and Clostridium difficile, Clin Infect Dis, 46, 491, 10.1086/526535
Assicot, 1993, High serum procalcitonin concentrations in patients with sepsis and infection, Lancet, 341, 515, 10.1016/0140-6736(93)90277-N
Nijsten, 2000, Procalcitonin behaves as a fast responding acute phase protein in vivo and in vitro, Crit Care Med, 28, 458, 10.1097/00003246-200002000-00028
Harbarth, 2001, Diagnostic value of procalcitonin, interleukin-6, and interleukin-8 in critically ill patients admitted with suspected sepsis, Am J Respir Crit Care Med, 164, 396, 10.1164/ajrccm.164.3.2009052
Simon, 2004, Serum procalcitonin and C-reactive protein levels as markers of bacterial infection: a systematic review and meta-analysis, Clin Infect Dis, 39, 206, 10.1086/421997
Tang, 2007, Accuracy of procalcitonin for sepsis diagnosis in critically ill patients: systematic review and meta-analysis, Lancet Infect Dis, 7, 210, 10.1016/S1473-3099(07)70052-X
Becker, 2008, Procalcitonin assay in systemic inflammation, infection, and sepsis: clinical utility and limitations, Crit Care Med, 36, 941, 10.1097/CCM.0B013E318165BABB
Castelli, 2009, Procalcitonin as a prognostic and diagnostic tool for septic complications after major trauma, Crit Care Med, 37, 1845, 10.1097/CCM.0b013e31819ffd5b
Svoboda, 2007, Can procalcitonin help us in timing of re-intervention in septic patients after multiple trauma or major surgery?, Hepatogastroenterology, 54, 359
Christ-Crain, 2004, Effect of procalcitonin-guided treatment on antibiotic use and outcome in lower respiratory tract infections: cluster-randomised, single-blinded intervention trial, Lancet, 363, 600, 10.1016/S0140-6736(04)15591-8
Christ-Crain, 2006, Procalcitonin guidance of antibiotic therapy in community-acquired pneumonia: a randomized trial, Am J Respir Crit Care Med, 174, 84, 10.1164/rccm.200512-1922OC
Stolz, 2007, Antibiotic treatment of exacerbations of COPD: a randomized, controlled trial comparing procalcitonin-guidance with standard therapy, Chest, 131, 9, 10.1378/chest.06-1500
Nobre, 2008, Use of procalcitonin to shorten antibiotic treatment duration in septic patients: a randomized trial, Am J Respir Crit Care Med, 177, 498, 10.1164/rccm.200708-1238OC
Schuetz, 2009, Effect of procalcitonin-based guidelines vs standard guidelines on antibiotic use in lower respiratory tract infections: the ProHOSP randomized controlled trial, JAMA, 302, 1059, 10.1001/jama.2009.1297
Hochreiter, 2009, Procalcitonin to guide duration of antibiotic therapy in intensive care patients: a randomized prospective controlled trial, Crit Care, 13, R83, 10.1186/cc7903
Bouadma, 2010, Use of procalcitonin to reduce patients' exposure to antibiotics in intensive care units (PRORATA trial): a multicentre randomised controlled trial, Lancet, 375, 463, 10.1016/S0140-6736(09)61879-1
Hohn, 2013, Procalcitonin-guided algorithm to reduce length of antibiotic therapy in patients with severe sepsis and septic shock, BMC Infect Dis, 13, 158, 10.1186/1471-2334-13-158
Deliberato, 2013, Clinical and economic impact of procalcitonin to shorten antimicrobial therapy in septic patients with proven bacterial infection in an intensive care setting, Diagn Microbiol Infect Dis, 76, 266, 10.1016/j.diagmicrobio.2013.03.027
Shehabi, 2014, Procalcitonin algorithm in critically ill adults with undifferentiated infection or suspected sepsis. A randomized controlled trial, Am J Respir Crit Care Med, 190, 1102, 10.1164/rccm.201408-1483OC
Kopterides, 2010, Procalcitonin-guided algorithms of antibiotic therapy in the intensive care unit: a systematic review and meta-analysis of randomized controlled trials, Crit Care Med, 38, 2229, 10.1097/CCM.0b013e3181f17bf9
Wacker, 2013, Procalcitonin as a diagnostic marker for sepsis: a systematic review and meta-analysis, Lancet Infect Dis, 13, 426, 10.1016/S1473-3099(12)70323-7
van de Sande-Bruinsma, 2008, Antimicrobial drug use and resistance in Europe, Emerg Infect Dis, 14, 1722, 10.3201/eid1411.070467
Dellinger, 2013, Surviving sepsis campaign: international guidelines for management of severe sepsis and septic shock: 2012, Crit Care Med, 41, 580, 10.1097/CCM.0b013e31827e83af
Brinkman, 2011, External validation of acute physiology and chronic health evaluation IV in Dutch intensive care units and comparison with acute physiology and chronic health evaluation II and simplified acute physiology score II, J Crit Care, 26, 105.e11, 10.1016/j.jcrc.2010.07.007
Bland, 1995, Multiple significance tests: the Bonferroni method, BMJ, 310, 170, 10.1136/bmj.310.6973.170
Garnacho-Montero, 2014, De-escalation of empirical therapy is associated with lower mortality in patients with severe sepsis and septic shock, Intensive Care Med, 40, 32, 10.1007/s00134-013-3077-7
Schuetz, 2012, Procalcitonin to guide initiation and duration of antibiotic treatment in acute respiratory infections: an individual patient data meta-analysis, Clin Infect Dis, 55, 651, 10.1093/cid/cis464
Vincent, 2014, Sepsis biomarkers. Values and limitations, Am J Resp Crit Care Med, 190, 1081, 10.1164/rccm.201410-1895ED